| ABR-OPA1-08181-C100 | PAb to MMP-18, Hinge Region (human) | 100 µg |
| ABR-OPA1-08182-C100 | PAb to MMP-18 (CT) (human) | 100 µg |
| ABR-OPA1-08190-C100 | PAb to MMP-19, Hinge Region (human) | 100 µg |
| ABR-OPA1-08191-C100 | PAb to MMP-19 (CT) (human) | 100 µg |
| ABR-OPA1-08192-C100 | PAb to MMP-19 (NT) (human) | 100 µg |
| ABR-OPA1-08193-C100 | PAb to MMP-19, Propeptide Region (human) | 100 µg |
| ABR-OPA1-08200-C100 | PAb to MMP-20, Hinge Region (human) | 100 µg |
| ABR-OPA1-08201-C100 | PAb to MMP-20 (CT) (human) | 100 µg |
| ABR-OPA1-08202-C100 | PAb to MMP-20 (NT) (human) | 100 µg |
| ABR-OPA1-08203-C100 | PAb to MMP-20, Propeptide Region (human) | 100 µg |
| ABR-OPA1-08230-C100 | PAb to MMP-23, Hinge Region (human) | 100 µg |
| ABR-OPA1-08231-C100 | PAb to MMP-23 (CT) (human) | 100 µg |
| ABR-OPA1-08232-C100 | PAb to MMP-23 (NT) (human) | 100 µg |
| ABR-OPA1-08240-C100 | PAb to MMP-24, Cytoplasmic Domain (human) | 100 µg |
| ABR-OPA1-08241-C100 | PAb to MMP-24, Hinge Region (human) | 100 µg |
| ABR-OPA1-08242-C100 | PAb to MMP-24 (NT) (human) | 100 µg |
| ABR-OPA1-08243-C100 | PAb to MMP-24, Propeptide Region (human) | 100 µg |
| ABR-OPA1-08510-C100 | PAb to TIMP-1, Loop 3 (human) | 100 µg |
| ABR-OPA1-08511-C100 | PAb to TIMP-1, Loop 1 & 2 (human) | 100 µg |
| ABR-OPA1-08512-C100 | PAb to TIMP-1 (CT) | 100 µg |
| ABR-OPA1-08520-C100 | PAb to TIMP-2 (CT) (human) | 100 µg |
| ABR-OPA1-08521-C100 | PAb to TIMP-2, Loop 1 (human) | 100 µg |
| ABR-OPA1-08522-C100 | PAb to TIMP-2, Loop 3 (human) | 100 µg |
| ABR-OPA1-08530-C100 | PAb to TIMP-3, Loop 1 (human) | 100 µg |
| ABR-OPA1-08531-C100 | PAb to TIMP-3 (CT) (human) | 100 µg |
| ABR-OPA1-08532-C100 | PAb to TIMP-3, Loop 3 (human) | 100 µg |
| ABR-OPA1-08540-C100 | PAb to TIMP-4 (CT) (human) | 100 µg |
| ABR-OPA1-08541-C100 | PAb to TIMP-4, Loop 1 (human) | 100 µg |
| ABR-OPA1-08542-C100 | PAb to TIMP-4, Loop 3 (human) | 100 µg |
| ABR-OPA1-08543-C100 | PAb to TIMP-4, Loop 2 (human) | 100 µg |
| ABR-OPA1-08700-C100 | PAb to BMP-1 (Long Form) (CT) (human) | 100 µg |
| ABR-OPA1-08701-C100 | PAb to BMP-1, CUB-2 Domain (human) | 100 µg |
| ABR-OPA1-08702-C100 | PAb to BMP-1 (NT) (human) | 100 µg |
| ABR-OPA1-08801-C100 | PAb to mu-Calpain (NT) | 100 µg |
| ABR-OPA1-08802-C100 | PAb to mu-Calpain, Domain-I | 100 µg |
| ABR-OPA1-08803-C100 | PAb to mu-Calpain, Domain-IV | 100 µg |
| ABR-OPA1-08804-C100 | PAb to mu-Calpain, Domain-IV | 100 µg |
| ABR-OPA1-08805-C100 | PAb to m-Calpain, Domain-III | 100 µg |
| ABR-OPA1-08806-C100 | PAb to m-Calpain (CT) | 100 µg |
| ABR-OPA1-08807-C100 | PAb to m-Calpain (NT) (human) | 100 µg |
| ABR-OPA1-08808-C100 | PAb to m-Calpain, Domain-III | 100 µg |
| ABR-OPA1-08809-C100 | PAb to Calpain-3, Domain-III (human) | 100 µg |
| ABR-OPA1-08810-C100 | PAb to Calpain-3, Domain-II (human) | 100 µg |
| ABR-OPA1-08811-C100 | PAb to Calpain-3, Domain-III (human) | 100 µg |
| ABR-OPA1-08812-C100 | PAb to Calpain-3, Domain-I (human) | 100 µg |
| ABR-OPA1-08813-C100 | PAb to Calpain-5 (NT) | 100 µg |
| ABR-OPA1-08814-C100 | PAb to Calpain-5 (CT) | 100 µg |
| ABR-OPA1-08815-C100 | PAb to Calpain-5, Domain-II | 100 µg |
| ABR-OPA1-08816-C100 | PAb to Calpain-5, Domain-III | 100 µg |
| ABR-OPA1-08817-C100 | PAb to Calpain-6, Domain-I | 100 µg |
| ABR-OPA1-08818-C100 | PAb to Calpain-6, Domain-II (human) | 100 µg |
| ABR-OPA1-08819-C100 | PAb to Calpain-6, Domain-T | 100 µg |
| ABR-OPA1-08820-C100 | PAb to Calpain-7, Domain-I (human) | 100 µg |
| ABR-OPA1-08821-C100 | PAb to Calpain-7, Domain-N (human) | 100 µg |
| ABR-OPA1-08822-C100 | PAb to LP-82/85 Calpain, Domain-III (human) | 100 µg |
| ABR-OPA1-08823-C100 | PAb to LP-85 Calpain, Domain-F503III (human) | 100 µg |
| ABR-OPA1-10080-1 | PAb to p38 | 1 Vial |
| ABR-OPA1-10100-1 | PAb to Epidermal Growth Factor Receptor [EGFR] | 1 Vial |
| ABR-OPA1-10110-1 | PAb to Vascular Endothelial Growth Factor [VEGF] (human) | 1 Vial |
| ABR-OPA1-10980-1 | PAb to Influenza A Virus Haemagglutinin [HA] Tag | 1 Vial |
| ABR-OPA1-15001-C050 | PAb to Adenosine Receptor A1 (human) | 50 µg |
| ABR-OPA1-15003-C050 | PAb to S1P1 (human) (NT) (extracellular) | 50 µg |
| ABR-OPA1-15004-C050 | PAb to S1P1 (human) (CT) | 50 µg |
| ABR-OPA1-15006-C050 | PAb to Lysophosphatidic Acid Receptor 3 (human) | 50 µg |
| ABR-OPA1-15007-C050 | PAb to S1P2 (human) (cytoplasmic loop) | 50 µg |
| ABR-OPA1-15008-C050 | PAb to S1P2 (human) (CT) | 50 µg |
| ABR-OPA1-15010-C050 | PAb to S1P3 (human) (CT) | 50 µg |
| ABR-OPA1-15011-C050 | PAb to Melanocortin 4 Receptor (human) | 50 µg |
| ABR-OPA1-15012-C050 | PAb to Melanocortin 1 Receptor (human) | 50 µg |
| ABR-OPA1-15013-C050 | PAb to Melanocortin 1 Receptor (human) | 50 µg |
| ABR-OPA1-15015-C050 | PAb to Prostaglandin F2-alpha Receptor (human) (extracellular loop) | 50 µg |
| ABR-OPA1-15016-C050 | PAb to Rhodopsin (human) | 50 µg |
| ABR-OPA1-15017-C050 | PAb to Neuropeptide Y Receptor Type 1 (human) | 50 µg |
| ABR-OPA1-15018-C050 | PAb to Neuropeptide Y Receptor Type 4 (human) (extracellular loop) | 50 µg |
| ABR-OPA1-15019-C050 | PAb to Neuropeptide Y Receptor Type 4 (human) | 50 µg |
| ABR-OPA1-15020-C050 | PAb to Neuropeptide Y Receptor Type 4 (human) (CT) | 50 µg |
| ABR-OPA1-15021-C050 | PAb to Neuropeptide Y Receptor Type 5 (human) | 50 µg |
| ABR-OPA1-15022-C050 | PAb to Neuropeptide Y Receptor Type 5 (human) | 50 µg |
| ABR-OPA1-15023-C050 | PAb to Neuropeptide Y Receptor Type 5 (human) | 50 µg |
| ABR-OPA1-15024-C050 | PAb to Prolactin Releasing Hormone Receptor (human) | 50 µg |
| ABR-OPA1-15025-C050 | PAb to Chemokine Receptor-like 2 (human) | 50 µg |
| ABR-OPA1-15026-C050 | PAb to Chemokine Receptor-like 2 (human) | 50 µg |
| ABR-OPA1-15027-C050 | PAb to G Protein-Coupled Receptor GPR22 (human) | 50 µg |
| ABR-OPA1-15028-C050 | PAb to 5-HT2B Receptor (human) (extracellular loop) | 50 µg |
| ABR-OPA1-15029-C050 | PAb to Latrophilin-1 (human) (NT) (extracellular) | 50 µg |
| ABR-OPA1-15030-C050 | PAb to Latrophilin-2 (human) (NT) (extracellular) | 50 µg |
| ABR-OPA1-15031-C050 | PAb to Latrophilin-2 (human) | 50 µg |
| ABR-OPA1-15032-C050 | PAb to Latrophilin-2 (human) (CT) | 50 µg |
| ABR-OPA1-15033-C050 | PAb to Latrophilin-3 (human) (CT) | 50 µg |
| ABR-OPA1-15034-C050 | PAb to Peropsin (human) | 50 µg |
| ABR-OPA1-15035-C050 | PAb to GPR2/CCR10 (human) | 50 µg |
| ABR-OPA1-15036-C050 | PAb to CCR10 (human) | 50 µg |
| ABR-OPA1-15037-C050 | PAb to G Protein-Coupled Receptor GPR31 (human) | 50 µg |
| ABR-OPA1-15038-C050 | PAb to G Protein-Coupled Receptor GPR31 (human) | 50 µg |
| ABR-OPA1-15039-C050 | PAb to Histamine H1 Receptor (human) | 50 µg |
| ABR-OPA1-15040-C050 | PAb to G Protein-Coupled Receptor GPR30 (human) | 50 µg |
| ABR-OPA1-15041-C050 | PAb to G Protein-Coupled Receptor GPR30 (human) | 50 µg |
| ABR-OPA1-15042-C050 | PAb to 5-HT2B Receptor (human) (NT) (extracellular) | 50 µg |
| ABR-OPA1-15043-C050 | PAb to alpha1d-Adrenergic Receptor (human) | 50 µg |
| ABR-OPA1-15044-C050 | PAb to G Protein-Coupled Receptor GPR3 (human) | 50 µg |
| ABR-OPA1-15045-C050 | PAb to Thyrotropin-Releasing Hormone Receptor (human) | 50 µg |
| ABR-OPA1-15046-C050 | PAb to Glucagon-like Peptide 1 Receptor [GLP1R] (human) | 50 µg |
| ABR-OPA1-15047-C050 | PAb to Glucagon-like Peptide 1 Receptor [GLP1R] (human) | 50 µg |
| ABR-OPA1-15048-C050 | PAb to G Protein-Coupled Receptor GPR3 (human) | 50 µg |
| ABR-OPA1-15049-C050 | PAb to TM7XN1/GPR56 (human) | 50 µg |
| ABR-OPA1-15050-C050 | PAb to Retinoic Acid-induced 3 (human) | 50 µg |
| ABR-OPA1-15051-C050 | PAb to Platelet Activating Receptor Homolog (human) (extracellular loop) | 50 µg |
| ABR-OPA1-15052-C050 | PAb to Platelet Activating Receptor Homolog (human) (CT) | 50 µg |
| ABR-OPA1-15053-C050 | PAb to G Protein-Coupled Receptor GPR49 (human) | 50 µg |
| ABR-OPA1-15054-C050 | PAb to G Protein-Coupled Receptor GPR49 (human) | 50 µg |
| ABR-OPA1-15055-C050 | PAb to Adenosine Receptor A2a (human) | 50 µg |
